In a study published in , scientists investigated a protein called SYK (Spleen Tyrosine Kinase). They knew SYK was present in blood cancers but weren't sure exactly how it contributed to the disease. They discovered that SYK acts as a "partner in crime" with another protein called FLT3 , which is frequently mutated in leukemia patients. The 195RAR Mutation
In scientific research, "195RAR" refers to a specific genetic mutation used to study how certain proteins interact within the body, particularly in the context of cancer development. 195rar
The story of is a technical one, centered on the SYK protein and its role in Acute Myeloid Leukemia (AML) . Researchers used this mutation to unlock a secret about how cancer cells survive and resist treatment. The Mystery of the SYK Protein In a study published in , scientists investigated
By changing a specific sequence of amino acids from to GAL , researchers created a mutant version of the protein. The 195RAR Mutation In scientific research, "195RAR" refers
Because this specific interaction is so vital for the cancer to progress, it identified a new potential "weak spot" that future drugs could target to treat AML more effectively.
SYK must physically touch FLT3 to activate it.
SYK Is a Critical Regulator of FLT3 in Acute Myeloid Leukemia